In the past, cancer treatment was a scorched-earth affair: zero distinguishing between healthy cells and their cancer counterparts. The proprietary Fortis approach directs precision-therapies to CD46 proteins — while sparing normal tissues.
We’ve brought together many of the smartest minds in technology and medicine to finally make treating tumor cells a simple task of identifying a target… and hitting it. No scattershot or shotgun approach, just total precision. And that can make all the difference.